Samsung Biologics: largest shareholders' stake falls to 74.29% from 74.30%
Samsung Biologics' largest shareholders' combined stake fell to 74.29% as of Oct. 6, from 74.30% on Sept. 7, a decrease of 1,492 shares.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.